Latest news with #ArtGarfunkel
Forbes
4 days ago
- Entertainment
- Forbes
Paul Simon Delivers As ‘A Quiet Celebration' Tour Winds Down
Paul Simon performs on stage during his 'A Quiet Celebration' tour. Wednesday, May 21, 2025 at ... More Symphony Center in Chicago, IL 'Here's a… an old song,' said Paul Simon with a smile on stage in Chicago. 'I suddenly realized they're all old songs,' he said softly with a wink on opening night of a sold out three evening stand at Symphony Center, part of his 'A Quiet Celebration' return run. Few songwriters can match the canon of music Simon, 83, has meticulously crafted over the course of more than six decades. Partnering with Art Garfunkel, Simon moved over 100 million records globally, tacking on another 35 million albums sold as a solo artist, rendering him one of the best selling artists of all time. The duo's final studio album Bridge Over Troubled Water stood for a spell as the best selling album ever following its release in 1970, with Simon continually experimenting with an array of sounds in his wonderfully diverse body of solo work, going on to move in excess of 16 million copies of his 1986 opus Graceland. Paul Simon performs on stage during his 'A Quiet Celebration' tour. Wednesday, May 21, 2025 at ... More Symphony Center in Chicago, IL Following a farewell tour in 2018, Simon has appeared on stage a handful of times but 'A Quiet Celebration' marks his first full tour since, with the legendary singer and songwriter appearing for multi night runs in each city, performing in smaller theaters better equipped to support and showcase the nuance in his new music better than the arenas he could otherwise easily fill (a North American run which continues this weekend in San Francisco, California ahead of closing shows in Vancouver, British Columbia July 26 through 28 and Seattle, Washington on July 31 and August 2 and 3). At the heart of the incredible return run lies Simon's latest album Seven Psalms, a spiritual affair inspired by the old testament's Book of Psalms which appears on record as an acoustic suite: seven unbroken songs ruminating upon life and mortality which were designed to be absorbed by the listener in full, with the carefully chosen rooms on this tour supporting Simon's mission. Paul Simon performs on stage during his 'A Quiet Celebration' tour. Wednesday, May 21, 2025 at ... More Symphony Center in Chicago, IL On stage at Symphony Center, home to the Chicago Symphony Orchestra, Simon and company opened the show with the new album uninterrupted over the course of about 35 minutes, closing the performance with both deep cuts and hits over about two hours and 15 minutes. 'The Lord' read the screen flanking the band as Simon got going with sparse acoustic guitar while voices built the conclusion of the new album's opening track. Flute cut through xylophone and percussion early as more guitar and timpani rang out later. That dueling percussion lent 'My Professional Opinion' a bit of a shuffle while Simon plucked in an almost flamenco fashion during 'Your Forgiveness.' Paul Simon performs on stage during his 'A Quiet Celebration' tour. Wednesday, May 21, 2025 at ... More Symphony Center in Chicago, IL Vocalist Edie Brickell, Simon's wife of 33 years, joined for both 'The Sacred Harp' and 'Wait,' with the backing band swelling to 12 as Simon and Brickell harmonized on the chorus of the former while church bells brought the stunning full album performance of the new Seven Psalms to a close moments later. 'This is the first time since COVID that I'm able to play with my fellow musicians,' noted Simon at the top of the show, setting up the album suite. 'The second half is a bunch of hits. Some deep tracks - sort of,' explained the songwriter. 'Songs I always liked - but haven't played live much before. I hope you enjoy yourselves.' Slide guitar, flute and fiddle fueled a hootenanny as Simon donned his trademark baseball cap during 'Graceland." Simon started 'Slip Slidin' Away' solo acoustic before dusting off 'Train in the Distance' from 1983's Hearts and Bones record. 'Here's a song from the Simon & Garfunkel days,' he said, characteristically underselling 'Homeward Bound' as the second set began to find its footing. Paul Simon performs on stage during his 'A Quiet Celebration' tour. Wednesday, May 21, 2025 at ... More Symphony Center in Chicago, IL One of the great storytellers, Simon was in fine form on stage, returning to Hearts and Bones as he told the story behind 'The Late Great Johnny Ace,' a highlight on opening night in Chicago. 'Here's a song direct from a childhood memory…' he began. 'When I was an adolescent, there was a blues singer named Johnny Ace. His #1 record was 'Pledging My Love.' I loved that song,' Simon continued, explaining how Ace accidentally shot himself on Christmas day in 1954. 'I heard it the next day on the radio. The DJ said, 'We're gonna play his new song and from now on we're gonna call him the late great Johnny Ace.'' Simon conducted a bit as drums stomped in, gesturing left toward flute, violin and cello as images of John Lennon and John F. Kennedy appeared on screen as Simon namechecked them lyrically (also both victims of gun violence). Paul Simon performs on stage during his 'A Quiet Celebration' tour. Wednesday, May 21, 2025 at ... More Symphony Center in Chicago, IL 'This next song comes from the Graceland album and it's written about a specific person,' said Simon, reintroducing fans to Joseph Shabalala of South African vocal group Ladysmith Black Mambazo. 'Here to help me sing - and improve the performance vastly - is Edie Brickell,' said Simon dryly with a smile. While he experimented with South African sounds on Graceland (bassist Bakithi Kumalo, 69, who performed on the album, is back for this live run) it was authentic reggae he was after in 1972, working with Jimmy Cliff's backing band on 'Mother and Child Reunion.' Heading for home, Simon and company worked up 'Me and Julio Down Down by the Schoolyard' shortly thereafter as opening night neared encore. Paul Simon performs on stage during his 'A Quiet Celebration' tour. Wednesday, May 21, 2025 at ... More Symphony Center in Chicago, IL Returning to the stage, the Chicago faithful went berserk as Simon put his spin upon '50 Ways to Leave Your Lover,' clapping along slightly offbeat as he made his way back to the Simon & Garfunkel canon one more time. 'This song is called 'The Boxer,'' he said simply. Starting the legendary track on his own, the band came swooping in out of the first verse as the crowd roared, with Simon's arms spread wide as the band took a bow. Gazing to his left, Simon was clearly swept up in the moment as he wrapped up the evening with the iconic 'The Sound of Silence,' delivering both a stirring and stunning solo take on the unparalleled number to the rapt audience. 'In restless dreams I walked alone…' sang Paul Simon as 'A Quiet Celebration' drew to a close on opening night in the Windy City.
Yahoo
6 days ago
- Entertainment
- Yahoo
Paul Simon Sparks New Health Fears After Canceling Two Concerts Amid Ongoing Back Issues
Music icon Paul Simon is sparking new fears for his health after axing two upcoming shows due to excruciating back pain – leaving insiders fearing the 'Bridge Over Troubled Waters' singer is headed towards his sad last days. Now sources fear the 83-year-old voice of multiple generations is coming to grips that he's headed to the final curtain of his career — and life — as he is overwhelmed by a growing raft of physical ills. The shocking show cancellations last month came as the aging 83-year-old Graceland maestro must undergo a 'surgical procedure' to relieve 'unmanageable' back agony. As Globe has reported, the condition's the latest in a string of health woes including one that's robbed the 'Sound of Silence' singer of 96 percent of the hearing in his left ear back in 2023. The baffling and still undiagnosed hearing condition struck while Paul was working on his latest album, Seven Psalms, and kept him from touring and playing some of his more famous hits like, 'You Can Call Me Al.' 'Quite suddenly I lost most of the hearing in my left ear, and nobody has an explanation for it,' Paul says. 'My reaction to that was frustration and annoyance — not quite anger yet — because I thought it would pass, it would repair itself.' But sources say that only some of his hearing returned. Sources say the singer, who rocketed to super-stardom on a massive string of mid-1960s hits with his then-partner Art Garfunkel, has become resigned to his approaching final curtain. 'It's just the age we're at,' the musician notes. 'Gordon Lightfoot just passed away, Jeff Beck too. My generation's time is up.' Medical experts tell Globe that Paul's crippling issues are likely to grow worse — and his adoring public should prepare for his retirement. 'At his age, hearing, nerve and joint damage are only likely to increase,' says Dr. Gabe Mirkin, a Florida longevity specialist. 'The older we are, the harder it is to bounce back from such serious ailments.' A music industry source says Paul seems to be having trouble accepting the inevitable, adding: 'It must be total agony for him to come to terms with what is clearly a fast-approaching end.' Solve the daily Crossword
Yahoo
30-05-2025
- Entertainment
- Yahoo
MUSIC ICON ART GARFUNKEL GIVES HISTORIC CONCERT IN TEL AVIV PERFORMING WITH SON ART GARFUNKEL JR BEFORE AN AUDIENCE OF TENS OF THOUSANDS AMIDST ROCKET FIRE
Hi-res photo link found HERE. NEW YORK, May 30, 2025 /PRNewswire/ -- In a moment of profound cultural significance, music icon Art Garfunkel took the stage last night in Tel Aviv's Ha'Yarkon Park before a cheering crowd of over 50,000, becoming the first international artist to perform in Israel since the devastating attack at the Nova Music Festival in October 2023. Garfunkel was joined by his son, Art Garfunkel Jr. Prior to Garfunkel and Garfunkel taking the stage air raid sirens were heard due to missile fire reportedly targeting the concert in Tel Aviv. The father and son duo proceeded with their performance against a backdrop of missile interceptions. The emotional appearance of the family pair performing at Neshef Rock as Garfunkel & Garfunkel, soared on timeless classics including Bridge Over Troubled Water, The Sound of Silence, and Mrs. Robinson, weaving a musical thread between generations, resilience, and hope. The family duo's most recent album, Garfunkel & Garfunkel Father and Son, is available worldwide from BMG. Art Garfunkel Jr. was reported by Rolling Stone as one of Germany's most successful artists and continues to extend his own audience. "I am happy to be here in Israel," the 83-year-old performer told tens of thousands of cheering fans. "If Israel is in danger, the entire world is in danger," Garfunkel told the audience. "We all must not allow fear to define or control us. I am here with my entire family. Music is my gift from God, and my son Art Jr. is carrying our torch of music forward." Adding to the emotional weight of the evening, Garfunkel also performed The Boxer alongside Israeli rocker Aviv Geffen, uniting two eras of musical expression in a rare collaboration. Art was accompanied by his wife of many years, Kathryn "Kim" Luce Garfunkel—who is currently launching a new design and licensing initiative—and their younger son, Beau. The Garfunkel family's presence underscored the personal nature of this landmark event. Notably, Garfunkel has largely stepped back from public appearances and media in recent years making this live concert from Israel a rare and powerful moment. Media Contact:Victoria Varelavv@ View original content to download multimedia: SOURCE Carrberry Companies
Time of India
30-05-2025
- Entertainment
- Time of India
Aviv Geffen's Concert Featuring Art Garfunkel Fails To Stop While Houthis Launch Missiles At Israel
Israeli Defense Forces (IDF) investigate the failure of security forces during a Tel Aviv concert as Houthis launched missiles. An Aviv Geffen concert, joined by American rock legend Art Garfunkel, reportedly continued despite the attack on Israel. A ballistic missile was launched by Yemen's Iran-backed Houthis late May 29, as per reports. This triggered air raid sirens across central Israel, but Israeli singer Geffen's concert continued. As per Times of Israel, IDF says it received reports that attendees did not hear siren during concert. At the same time, about tens of thousand had gathered at Bloomfield Stadium for Israeli soccer cup finals. The game was halted for 10 minutes before resuming, as reported by local media. Watch-
Yahoo
04-04-2025
- Entertainment
- Yahoo
Music Icon Art Garfunkel Opens Up About His Experience with Psoriasis for The First Time in Partnership with Sun Pharma
8X Grammy Award-winning artist and Rock and Roll Hall of Fame inductee reveals his experience with ILUMYA®(tildrakizumab-asmn) as part of the "I LUV YA for The Long Haul" campaign. PRINCETON, N.J., April 4, 2025 /PRNewswire/ -- Today, Sun Pharma announced its partnership with music icon and ILUMYA® (tildrakizumab-asmn) patient, Art Garfunkel, as he shares his story of living with moderate-to-severe plaque psoriasis in-depth for the first time publicly. Art, who was named one of Rolling Stone's "100 Greatest Singers of All Time," launched his career in the acclaimed duo "Simon & Garfunkel." Through the "I LUV YA for The Long Haul" campaign, Art joins a community of ILUMYA patients shedding light on the emotional toll of psoriasis and empowering others living with the condition to find the best treatment for them. While nearly 8 million Americans live with plaque psoriasis, its impact is often unseen or covered up.1 Art, whose music has touched millions worldwide, lived silently with his psoriasis—until now. "With support from my wife, Kim, and a treatment I trust, I am finally ready to give my history with psoriasis a voice," said Art. "After struggling for decades, I finally started ILUMYA about two years ago, and experiencing clearer skin has helped me regain my confidence. I am excited to share my story as part of the I LUV YA campaign in the hope that it will encourage others to find the right treatment for them." The "I LUV YA for The Long Haul," originally launched in May 2024, highlights the emotional impact psoriasis can have on a patient's life and how support – whether that be from a doctor, friend, or family member – can help navigate the challenges of managing their condition. The multi-part video series highlights real-life patient stories, including Art and how his wife, Kim, provided that support for him. "We are so honored to partner with Art Garfunkel to share his ILUMYA story and to bring greater awareness to the impact psoriasis has beyond the physical symptoms," said Maureen Shannon, Head of Biologics Marketing at Sun Pharma. "Art's music has impacted millions and his experience, shared for the first time, is sure to leave a lasting impression." To learn more about Art Garfunkel's experience and to learn more about ILUMYA as a treatment option, visit About Plaque Psoriasis Plaque psoriasis is a chronic, autoimmune disease that results in an overactive immune system and causes inflammation in the body, leading to symptoms like plaques, redness and flakes. It is estimated that nearly 8 million Americans live with plaque psoriasis.1 In plaque psoriasis, skin cells grow more rapidly than normal, rising to the surface of the skin in days rather than weeks. Life with plaque psoriasis can also be more than the physical symptoms – there can be an emotional impact as well. About ILUMYA (tildrakizumab-asmn) ILUMYA (tildrakizumab-asmn) is a humanized lgG1/k monoclonal antibody designed to selectively bind to the p19 subunit of interleukin-23 (IL-23) and inhibit its interaction with the IL-23 receptor, leading to inhibition of the release of pro-inflammatory cytokines and chemokines. ILUMYA is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy, in the United States. ILUMYA has also been approved for moderate-to-severe plaque psoriasis in Australia and Japan, and under the brand name ILUMETRI® in Europe, where it is marketed by Almirall. INDICATIONS AND USAGE ILUMYA (tildrakizumab-asmn) is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. CONTRAINDICATIONSILUMYA is contraindicated in patients with a previous serious hypersensitivity reaction to tildrakizumab or to any of the excipients. IMPORTANT SAFETY INFORMATIONWARNINGS AND PRECAUTIONSHypersensitivityCases of angioedema and urticaria occurred in ILUMYA-treated subjects in clinical trials. If a serious allergic reaction occurs, discontinue ILUMYA immediately and initiate appropriate therapy. InfectionsILUMYA may increase the risk of infection. Treatment with ILUMYA should not be initiated in patients with a clinically important active infection until the infection resolves or is adequately treated. Consider the risks and benefits of treatment prior to prescribing ILUMYA in patients with a chronic infection or a history of recurrent infection. Instruct patients receiving ILUMYA to seek medical help if signs or symptoms of clinically important chronic or acute infection occur. If a patient develops a clinically important or serious infection, or is not responding to standard therapy, closely monitor and consider discontinuation of ILUMYA until the infection resolves. Pretreatment Evaluation for TuberculosisEvaluate patients for tuberculosis (TB) infection prior to initiating treatment with ILUMYA. Do not administer ILUMYA to patients with active TB infection. Initiate treatment of latent TB prior to administering ILUMYA. Consider anti-TB therapy prior to initiation of ILUMYA in patients with a past history of latent or active TB in whom an adequate course of treatment cannot be confirmed. Patients receiving ILUMYA should be monitored closely for signs and symptoms of active TB during and after treatment. ImmunizationsPrior to initiating therapy with ILUMYA, consider completion of all age-appropriate immunizations according to current immunization guidelines. Patients treated with ILUMYA should not receive live vaccines. Adverse ReactionsThe most common (≥1%) adverse reactions associated with ILUMYA treatment that were more frequent than in the placebo group are upper respiratory infections, injection-site reactions, and diarrhea. Please see Full Prescribing Information. About Sun Pharmaceutical Industries LimitedSun Pharma is the world's leading specialty generics company with a presence in Specialty, Generics and Consumer Healthcare products. It is the largest pharmaceutical company in India and is a leading generic company in the U.S. as well as Global Emerging Markets. Sun's high-growth Global Specialty portfolio spans innovative products in dermatology, ophthalmology, and onco-dermatology and accounts for over 18% of company sales. The company's vertically integrated operations deliver high-quality medicines, trusted by physicians and consumers in over 100 countries. Its manufacturing facilities are spread across six continents. Sun Pharma is proud of its multi-cultural workforce drawn from over 50 nations. For further information, please visit & follow us on LinkedIn & X (Formerly Twitter). DisclaimerStatements in this "Document" describing the Company's objectives, projections, estimates, expectations, plans or predictions or industry conditions or events may be "forward looking statements" within the meaning of applicable securities laws and regulations. Actual results, performance or achievements could differ materially from those expressed or implied. The Company undertakes no obligation to update or revise forward-looking statements to reflect developments or circumstances that arise or to reflect the occurrence of unanticipated developments/circumstances after the date hereof. References View original content to download multimedia: SOURCE Sun Pharmaceutical Industries Inc., USA (Sun Pharma) Sign in to access your portfolio
